250 related articles for article (PubMed ID: 20376080)
21. C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia.
Alberich-Jordà M; Wouters B; Balastik M; Shapiro-Koss C; Zhang H; Di Ruscio A; Radomska HS; Ebralidze AK; Amabile G; Ye M; Zhang J; Lowers I; Avellino R; Melnick A; Figueroa ME; Valk PJ; Delwel R; Tenen DG
J Clin Invest; 2012 Dec; 122(12):4490-504. PubMed ID: 23160200
[TBL] [Abstract][Full Text] [Related]
22. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.
Pabst T; Mueller BU; Zhang P; Radomska HS; Narravula S; Schnittger S; Behre G; Hiddemann W; Tenen DG
Nat Genet; 2001 Mar; 27(3):263-70. PubMed ID: 11242107
[TBL] [Abstract][Full Text] [Related]
23. A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx.
Ryo A; Hirai A; Nishi M; Liou YC; Perrem K; Lin SC; Hirano H; Lee SW; Aoki I
J Biol Chem; 2007 Dec; 282(50):36671-81. PubMed ID: 17938171
[TBL] [Abstract][Full Text] [Related]
24. Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations.
Radomska HS; Bassères DS; Zheng R; Zhang P; Dayaram T; Yamamoto Y; Sternberg DW; Lokker N; Giese NA; Bohlander SK; Schnittger S; Delmotte MH; Davis RJ; Small D; Hiddemann W; Gilliland DG; Tenen DG
J Exp Med; 2006 Feb; 203(2):371-81. PubMed ID: 16446383
[TBL] [Abstract][Full Text] [Related]
25. RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein alpha function.
Tokita K; Maki K; Mitani K
Cancer Sci; 2007 Nov; 98(11):1752-7. PubMed ID: 17894555
[TBL] [Abstract][Full Text] [Related]
26. Acetylation of C/EBPα inhibits its granulopoietic function.
Bararia D; Kwok HS; Welner RS; Numata A; Sárosi MB; Yang H; Wee S; Tschuri S; Ray D; Weigert O; Levantini E; Ebralidze AK; Gunaratne J; Tenen DG
Nat Commun; 2016 Mar; 7():10968. PubMed ID: 27005833
[TBL] [Abstract][Full Text] [Related]
27. Disruption of the C/EBPα-miR-182 balance impairs granulocytic differentiation.
Wurm AA; Zjablovskaja P; Kardosova M; Gerloff D; Bräuer-Hartmann D; Katzerke C; Hartmann JU; Benoukraf T; Fricke S; Hilger N; Müller AM; Bill M; Schwind S; Tenen DG; Niederwieser D; Alberich-Jorda M; Behre G
Nat Commun; 2017 Jun; 8(1):46. PubMed ID: 28663557
[TBL] [Abstract][Full Text] [Related]
28. Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Hickey CJ; Schwind S; Radomska HS; Dorrance AM; Santhanam R; Mishra A; Wu YZ; Alachkar H; Maharry K; Nicolet D; Mrózek K; Walker A; Eiring AM; Whitman SP; Becker H; Perrotti D; Wu LC; Zhao X; Fehniger TA; Vij R; Byrd JC; Blum W; Lee LJ; Caligiuri MA; Bloomfield CD; Garzon R; Marcucci G
Blood; 2013 Jan; 121(1):159-69. PubMed ID: 23100311
[TBL] [Abstract][Full Text] [Related]
29. CDK2 destabilizes tumor suppressor C/EBPα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia.
Thacker G; Mishra M; Sharma A; Singh AK; Sanyal S; Trivedi AK
J Cell Biochem; 2020 Apr; 121(4):2839-2850. PubMed ID: 31692040
[TBL] [Abstract][Full Text] [Related]
30. Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPalpha expression.
Zheng R; Friedman AD; Levis M; Li L; Weir EG; Small D
Blood; 2004 Mar; 103(5):1883-90. PubMed ID: 14592841
[TBL] [Abstract][Full Text] [Related]
31. EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.
Zjablovskaja P; Kardosova M; Danek P; Angelisova P; Benoukraf T; Wurm AA; Kalina T; Sian S; Balastik M; Delwel R; Brdicka T; Tenen DG; Behre G; Fiore F; Malissen B; Horejsi V; Alberich-Jorda M
Cell Death Differ; 2017 Apr; 24(4):705-716. PubMed ID: 28186500
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.
Grebien F; Vedadi M; Getlik M; Giambruno R; Grover A; Avellino R; Skucha A; Vittori S; Kuznetsova E; Smil D; Barsyte-Lovejoy D; Li F; Poda G; Schapira M; Wu H; Dong A; Senisterra G; Stukalov A; Huber KVM; Schönegger A; Marcellus R; Bilban M; Bock C; Brown PJ; Zuber J; Bennett KL; Al-Awar R; Delwel R; Nerlov C; Arrowsmith CH; Superti-Furga G
Nat Chem Biol; 2015 Aug; 11(8):571-578. PubMed ID: 26167872
[TBL] [Abstract][Full Text] [Related]
33. The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia.
O'Connor C; Lohan F; Campos J; Ohlsson E; Salomè M; Forde C; Artschwager R; Liskamp RM; Cahill MR; Kiely PA; Porse B; Keeshan K
Oncogene; 2016 Oct; 35(40):5272-5281. PubMed ID: 26996668
[TBL] [Abstract][Full Text] [Related]
34. CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex.
Schmidt L; Heyes E; Scheiblecker L; Eder T; Volpe G; Frampton J; Nerlov C; Valent P; Grembecka J; Grebien F
Leukemia; 2019 Jul; 33(7):1608-1619. PubMed ID: 30679799
[TBL] [Abstract][Full Text] [Related]
35. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
36. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
[TBL] [Abstract][Full Text] [Related]
37. Pin1 promotes cell death in NGF-dependent neurons through a mechanism requiring c-Jun activity.
Barone MC; Desouza LA; Freeman RS
J Neurochem; 2008 Jul; 106(2):734-45. PubMed ID: 18419764
[TBL] [Abstract][Full Text] [Related]
38. Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways.
Lian X; Lin YM; Kozono S; Herbert MK; Li X; Yuan X; Guo J; Guo Y; Tang M; Lin J; Huang Y; Wang B; Qiu C; Tsai CY; Xie J; Gao ZJ; Wu Y; Liu H; Zhou XZ; Lu KP; Chen Y
J Hematol Oncol; 2018 May; 11(1):73. PubMed ID: 29848341
[TBL] [Abstract][Full Text] [Related]
39. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.
Wulf GM; Ryo A; Wulf GG; Lee SW; Niu T; Petkova V; Lu KP
EMBO J; 2001 Jul; 20(13):3459-72. PubMed ID: 11432833
[TBL] [Abstract][Full Text] [Related]
40. Regulation of granulocyte and monocyte differentiation by CCAAT/enhancer binding protein alpha.
Friedman AD; Keefer JR; Kummalue T; Liu H; Wang QF; Cleaves R
Blood Cells Mol Dis; 2003; 31(3):338-41. PubMed ID: 14636649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
